Form 8-K - Current report:
SEC Accession No. 0001104659-06-032170
Filing Date
2006-05-08
Accepted
2006-05-08 17:23:02
Documents
5
Period of Report
2006-05-02
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-9273_28k.htm 8-K 22237
2 EX-99.1 a06-9273_2ex99d1.htm EX-99.1 7597
3 EX-99.2 a06-9273_2ex99d2.htm EX-99.2 73902
4 GRAPHIC g92732mai001.jpg GRAPHIC 8657
5 GRAPHIC g92732mci001.jpg GRAPHIC 8668
  Complete submission text file 0001104659-06-032170.txt   129546
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 06817778
SIC: 2836 Biological Products, (No Diagnostic Substances)